Cytocom, Inc.
CBLI · NASDAQ
6/30/2021 | 3/31/2021 | 12/31/2020 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | $84,670 | $74,692 | $44,858 | $25,615 |
| - Cash | $13,777 | $14,359 | $1,946 | $2,721 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $70,893 | $60,333 | $42,912 | $22,894 |
| Revenue | $0 | $0 | $0 | $44 |
| % Growth | – | -100% | -100% | – |
| Gross Profit | $0 | $0 | $0 | $44 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$668 | -$536 | -$692 | -$752 |
| % Margin | – | – | -263,193,403,868,533.7% | -1,723.6% |
| Net Income | -$660 | -$538 | -$695 | -$745 |
| % Margin | – | – | -264,202,751,937,689.7% | -1,707.8% |
| EPS Diluted | -0.043 | -0.038 | -0.053 | -0.057 |
| % Growth | -12.7% | 29.2% | 6.8% | – |
| Operating Cash Flow | -$860 | -$363 | -$788 | -$683 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$860 | -$363 | -$788 | -$683 |